デフォルト表紙
市場調査レポート
商品コード
1496751

バイオ医薬品添加剤市場:製品、機能、用途別-2024-2030年の世界予測

Biopharmaceutical Excipients Market by Product (Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers), Function (Binders, Coatings, Disintegrants), Application - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 189 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.74円
バイオ医薬品添加剤市場:製品、機能、用途別-2024-2030年の世界予測
出版日: 2024年06月05日
発行: 360iResearch
ページ情報: 英文 189 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオ医薬品添加剤市場規模は2023年に22億9,000万米ドルと推計され、2024年には25億3,000万米ドルに達すると予測され、CAGR 10.75%で2030年には47億米ドルに達する見込みです。

バイオ医薬品添加剤とは、医薬品の製造、安定性、使用性、デリバリーを補助するためにバイオ医薬品の製剤に含まれる治療分子以外の物質です。バイオ医薬品添加剤は医薬品の製剤化において極めて重要な役割を果たします。その用途は結合剤、充填剤、希釈剤、崩壊剤、安定剤など多岐にわたる。高度で機能的なバイオ医薬品製剤に対する需要の高まりや、高分子開発のニーズの高まりが、バイオ医薬品添加剤の採用を促進しています。さらに、医薬品開発への投資の増加がバイオ医薬品添加剤の利用を後押ししています。しかしながら、バイオ医薬品製剤と原薬との適合性の問題は、大きな課題となっています。さらに、生物製剤やバイオシミラーの継続的な開発により、適合する賦形剤の必要性が高まっています。徐放性製剤の技術的進歩と代替投与経路の探求は、市場拡大の大きな可能性を提供します。

主な市場の統計
基準年[2023] 22億9,000万米ドル
予測年[2024] 25億3,000万米ドル
予測年 [2030] 47億米ドル
CAGR(%) 10.75%

地域別インサイト

南北アメリカでは、米国が製薬業界の堅調さ、研究開発への多額の投資、FDAの安定した承認数により、バイオ医薬品添加剤市場で圧倒的な地位を占めています。カナダはこの地域の需要に貢献しており、両国ともドラッグデリバリーと安定性を高める新規の多機能賦形剤に高い関心を示しています。欧州連合(EU)諸国は、厳格な規制基準を持つ確立された医薬品セクターを有しています。消費者のニーズは、高品質の原料を必要とするバイオシミラーや生物製剤の生産に牽引されています。EUによる研究革新プログラムへの継続的な投資は、バイオ医薬品の性能と安全性の向上を目的とした特許出願の可能性を含め、賦形剤開発への継続的なコミットメントを示しています。APAC地域では、新しい賦形剤の技術革新と開発に重点が置かれており、製薬業界のレベルアップを政府が強力に推進しています。ジェネリック医薬品の生産拠点であるインドでは、賦形剤の需要はコスト効率と国際規格への適合に合致しています。アジア太平洋全体では、多様な顧客ニーズが特定の賦形剤に対する需要を牽引しており、市場の成長を促進すると期待されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、バイオ医薬品添加剤市場におけるベンダーのポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、ビジネス戦略や製品満足度に関連する重要な指標を検証します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront(F)、Pathfinder(P)、Niche(N)、Vital(V)に分類されます。

市場シェア分析

市場シェア分析は、バイオ医薬品添加剤市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査した基準年の期間に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。

戦略分析と推奨

戦略分析は、世界マーケットで確固たる足場を築こうとする組織にとって不可欠です。企業は、バイオ医薬品添加剤市場における現在の地位を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 先進的かつ機能的なバイオ医薬品製剤の需要の高まり
      • 高分子開発の必要性の高まり
      • バイオシミラーの開発増加
      • ホルモンおよび遺伝子治療の需要増加
      • 世界中でワクチンの大量生産
    • 抑制要因
      • バイオ医薬品添加剤の高価格
    • 機会
      • バイオ医薬品製造のアウトソーシングの新たな動向
      • 機能性添加剤の需要が大幅に増加
      • 組み換えDNA技術の発展
    • 課題
      • バイオ医薬品添加剤の製造の複雑さと汚染の問題
      • 時間のかかるバイオ医薬品の臨床試験
  • 市場セグメンテーション分析
    • 製品:炭水化物は、製剤の安定性と患者のコンプライアンスのために医薬品製剤に使用される主要な賦形剤です。
    • 機能:生物学的製剤における防腐剤の利用を増やし、安定性を向上
    • 応用:薬物放出を制御するための高度なデリバリーシステムにおけるバイオ医薬品添加剤の重要性の高まり
  • 市場動向分析
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制枠組みの分析
  • 顧客のカスタマイズ

第6章 バイオ医薬品添加剤市場:製品別

  • 炭水化物
  • ポリオール
  • 可溶化剤および界面活性剤/乳化剤
  • 特殊添加剤

第7章 バイオ医薬品添加剤市場:機能別

  • バインダー
  • コーティング
  • 崩壊剤
  • 潤滑剤と滑剤
  • 医薬品充填剤
  • 防腐剤

第8章 バイオ医薬品添加剤市場:用途別

  • 高度な配信システム
  • オーラル
  • 非経口
  • 話題

第9章 南北アメリカのバイオ医薬品添加剤市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域のバイオ医薬品添加剤市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカのバイオ医薬品添加剤市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • ロケット、栄養補助食品向けの保湿成分3種を発売
    • Croda Pharma、添加剤製造施設の建設を開始

第13章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. BIOPHARMACEUTICAL EXCIPIENTS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BIOPHARMACEUTICAL EXCIPIENTS MARKET DYNAMICS
  • FIGURE 7. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. BIOPHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. BIOPHARMACEUTICAL EXCIPIENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DEXTROSE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DEXTROSE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUCROSE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUCROSE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SPECIALTY EXCIPIENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SPECIALTY EXCIPIENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL FILLERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL FILLERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ADVANCED DELIVERY SYSTEM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ADVANCED DELIVERY SYSTEM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PARENTERAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 109. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 121. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 136. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 156. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 158. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 160. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 167. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 168. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 169. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 170. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 171. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 172. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 173. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 179. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 180. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 181. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 182. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 183. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 184. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 185. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 191. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 192. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 193. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 194. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 195. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 196. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 197. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 198. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 203. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 204. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 205. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 206. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 207. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 208. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 209. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 215. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 216. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 217. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 218. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 219. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 220. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 221. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 228. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 230. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 232. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 239. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 240. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 241. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 242. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 243. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 244. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 245. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 263. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 264. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 265. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 266. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 267. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 268. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 269. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 273. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 274. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 275. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 276. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 277. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 278. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 279. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 280. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 281. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 285. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 286. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 287. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 288. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 289. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 290. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 291. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 292. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 293. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 294. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 309. DENMARK BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 310. DENMARK BIOPHARMACEUTICAL E
目次
Product Code: MRR-A339DAEFAD78

[189 Pages Report] The Biopharmaceutical Excipients Market size was estimated at USD 2.29 billion in 2023 and expected to reach USD 2.53 billion in 2024, at a CAGR 10.75% to reach USD 4.70 billion by 2030.

Biopharmaceutical excipients are substances other than therapeutic molecules that are included in a biopharmaceutical formulation to aid in the production, stability, usability, and delivery of the drug. Biopharmaceutical excipients play a pivotal role in drug formulation. Their applications span diverse categories, such as binders, fillers, diluents, disintegrants, and stabilizers. Rising demand for advanced and functional biopharmaceutical drug formulations and increasing need for large-molecule development are driving the adoption of biopharmaceutical excipients. In addition, rising investment in drug development is boosting the utilization of biopharmaceutical excipients. However, the compatibility issues of biopharmaceutical formulations with active pharmaceutical ingredients pose considerable challenges. Furthermore, the continuous development of biologics and biosimilars leads to an increased need for compatible excipients. Technological advancements in extended-release formulations and the exploration of alternative routes of administration provide significant potential for market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 2.29 billion
Estimated Year [2024] USD 2.53 billion
Forecast Year [2030] USD 4.70 billion
CAGR (%) 10.75%

Regional Insights

In the Americas, the United States stands as a dominant player within the biopharmaceutical excipients market due to a robust pharmaceutical industry, significant investment in R&D, and a steady number of FDA approvals. Canada contributes to regional demand, and both countries exhibit a high interest in novel, multifunctional excipients that enhance drug delivery and stability. European Union (EU) countries possess a well-established pharmaceutical sector with stringent regulatory standards. Consumer need is driven by the production of biosimilars and biologics that demand high-quality ingredients. Ongoing investments by the European Union in research and innovation programs indicate a continued commitment to excipient development, including potential patent applications that aim at improving the performance and safety of biopharmaceuticals. In the APAC region, the focus is on the innovation and development of new excipients and a strong government push for upgrading the pharmaceutical industry. In India, a hub for generic drug production, the excipient demand aligns with cost efficiency and compliance with international standards. Across the Asia Pacific, diverse customer needs steer the demand for specific excipients, which are expected to fuel market growth.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Biopharmaceutical Excipients Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising Demand for Advanced and Functional Biopharmaceutical Drug Formulations
      • Increasing Need for Large-Molecule Development
      • Increasing Development of Biosimilars
      • Increasing Demand for Hormone and Gene Therapy
      • Bulk Vaccine Production Worldwide
    • Market Restraints
      • High Price of Biopharmaceutical Excipients
    • Market Opportunities
      • Emerging Trends of Outsourcing for the Production of Biologics
      • Substantial Rise in Need of Functional Excipients
      • Developments in Recombinant DNA Technologies
    • Market Challenges
      • Manufacturing Complexities and Contamination Issues of Biopharmaceutical Excipients
      • Time Consuming Biopharmaceutical Clinical Trials
  • Market Segmentation Analysis
    • Product: Carbohydrates are prominent excipients used in pharmaceutical formulations for formulation stability and patient compliance
    • Function: Increasing utilization of preservatives in biologic formulation for improved stability
    • Application: Growing significance of biopharmaceutical excipients in advanced delivery systems for control drug release
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Biopharmaceutical Excipients Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Biopharmaceutical Excipients Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Roquette launches three moisture-protecting ingredients for nutraceuticals

Roquette has expanded its portfolio of biopharmaceutical excipients with the introduction of three new grades specifically tailored to enhance the stability of moisture-sensitive active pharmaceutical and nutraceutical ingredients. The newly unveiled grades are the partially pregelatinized starch Lycatab CT-LM and two microcrystalline cellulose variants, Microcel 103 SD and Microcel 113 SD, which provide an unparalleled combination of stabilizing properties and moisture protection. [Published On: 2023-10-26]

Croda Pharma Breaks Ground on Excipients Manufacturing Facility

Croda Pharma has initiated the construction of an advanced manufacturing facility in Lamar, Pennsylvania, focused on producing advanced biopharmaceutical excipients crucial for cutting-edge drug delivery systems. With a footprint of 23,680 square feet, this facility is poised to significantly bolster the production of ingredients vital for mRNA vaccines, gene therapies, and innovative cancer treatments, fulfilling an emerging demand in therapeutic modalities. [Published On: 2023-06-14]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Biopharmaceutical Excipients Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceutical Excipients Market, highlighting leading vendors and their innovative profiles. These include ABITEC Corporation, Actylis, Ashland Global Holdings Inc., BASF SE, Clariant International Ltd., Colorcon, Inc., Croda International PLC, DFE Pharma GmbH & Co KG, Eastman Chemical Company, Evonik Industries AG, Fuji Chemical Industries Co., Ltd., IMCD N.V., Innophos Holdings, Inc., J. Rettenmaier & Sohne GmbH + Co KG, Meggle Group GmbH, Merck KGaA, Roquette Freres S.A., Sigachi Industries Limited, Spectrum Laboratory Products, Inc., SPI Pharma, Inc., The Dow Chemical Company, The Lubrizol Corporation, VWR International, LLC by Avantor, and Wacker Chemie AG.

Market Segmentation & Coverage

This research report categorizes the Biopharmaceutical Excipients Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Carbohydrates
      • Dextrose
      • Starch
      • Sucrose
    • Polyols
      • Mannitol
      • Sorbitol
    • Solubilizers & Surfactants/Emulsifiers
      • Esters
      • Triglycerides
    • Specialty Excipients
  • Function
    • Binders
    • Coatings
    • Disintegrants
    • Lubricants & glidants
    • Pharmaceutical Fillers
    • Preservatives
  • Application
    • Advanced Delivery System
    • Oral
    • Parenteral
    • Topical
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Demand for Advanced and Functional Biopharmaceutical Drug Formulations
      • 5.1.1.2. Increasing Need for Large-Molecule Development
      • 5.1.1.3. Increasing Development of Biosimilars
      • 5.1.1.4. Increasing Demand for Hormone and Gene Therapy
      • 5.1.1.5. Bulk Vaccine Production Worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High Price of Biopharmaceutical Excipients
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Trends of Outsourcing for the Production of Biologics
      • 5.1.3.2. Substantial Rise in Need of Functional Excipients
      • 5.1.3.3. Developments in Recombinant DNA Technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Manufacturing Complexities and Contamination Issues of Biopharmaceutical Excipients
      • 5.1.4.2. Time Consuming Biopharmaceutical Clinical Trials
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Carbohydrates are prominent excipients used in pharmaceutical formulations for formulation stability and patient compliance
    • 5.2.2. Function: Increasing utilization of preservatives in biologic formulation for improved stability
    • 5.2.3. Application: Growing significance of biopharmaceutical excipients in advanced delivery systems for control drug release
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Biopharmaceutical Excipients Market, by Product

  • 6.1. Introduction
  • 6.2. Carbohydrates
  • 6.3. Polyols
  • 6.4. Solubilizers & Surfactants/Emulsifiers
  • 6.5. Specialty Excipients

7. Biopharmaceutical Excipients Market, by Function

  • 7.1. Introduction
  • 7.2. Binders
  • 7.3. Coatings
  • 7.4. Disintegrants
  • 7.5. Lubricants & glidants
  • 7.6. Pharmaceutical Fillers
  • 7.7. Preservatives

8. Biopharmaceutical Excipients Market, by Application

  • 8.1. Introduction
  • 8.2. Advanced Delivery System
  • 8.3. Oral
  • 8.4. Parenteral
  • 8.5. Topical

9. Americas Biopharmaceutical Excipients Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Biopharmaceutical Excipients Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Biopharmaceutical Excipients Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Roquette launches three moisture-protecting ingredients for nutraceuticals
    • 12.3.2. Croda Pharma Breaks Ground on Excipients Manufacturing Facility

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio